| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.005 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.005 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.005 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.094 | 0.006 |